Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Juno Medical Raises $5.4M in Seed Financing to Reimagine Primary Care for the 99%
Juno Medical, the modern doctor’s office that’s designed for the 99%, today announces $5.4 million in seed […]
2021 BioTech Breakthrough Awards Program Opens for Nominations
BioTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies, and products […]
London Femtech Vira Health Scores £1.5M Seed Funding for Helping Women Cope with Menopause
The news is just in that Vira Health has raised £1.5 million in a seed […]
Northern Ireland Pens Deal with First DataBank for Clinical Decision Tool
Health and Social Care Northern Ireland (HSCNI) have penned a deal with First DataBank to […]
Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and […]
3D Printing Transforming Medical Implants: 4D Biomaterials Picks Up £1.6M Funding
A medtech company based in Nottingham, 4D Biomaterials, which has developed a new biomaterial used for […]
Amanda Pritchard Appointed NHS Chief Executive
Amanda Pritchard has today been appointed as the new Chief Executive Officer of NHS England. […]
Amgen to Acquire Privately Held Teneobio for $900 Million in Cash With Future Contingent Milestone Payments
Amgen (NASDAQ: AMGN) and Teneobio today announced an agreement under which Amgen will acquire Teneobio, a […]
Inceptor Bio Announces the Appointment of Dr. Mark J. Gilbert as Chair of its Scientific Advisory Board
Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotechnology company, announced today […]
Aristea Completes $63 Million Series B Financing to Accelerate Clinical Development of Novel Immunotherapy Drugs for the Treatment of Orphan Diseases
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more